Recent Posts
Connect with:
Tuesday / June 25.
HomeminewsSynergeyes and BHVI Partner for Speciality Lens Development

Synergeyes and BHVI Partner for Speciality Lens Development

Eye care professionals will be better placed to meet the needs of myopes and presbyopes, following a partnership agreement between Brien Holden Vision Institute and hybrid specialty contact lens company SynergEyes.

The exclusive worldwide licensing agreement will enable the manufacture of design technologies developed by Brien Holden Vision Institute to augment the SynergEyes presbyopic package by offering the latest designs on the hybrid contact lens platform.

With around half of the world’s population predicted to be myopic by 2050, and the Baby Boomer generation now fully presbyopic, demand is expected to be high.

“SynergEyes seeks to improve quality of life for people by delivering on the hybrid platform innovative lens designs that solve age-old problems in a new way,” said James Kirchner, OD, President and CEO of SynergEyes. “Working with a recognised worldwide leader like the Brien Holden Vision Institute, we plan to bring an extended depth-of-focus lens design onto the hybrid platform to the global market.”

Brien Holden Vision Institute has developed new optical designs that incorporate an extended depth of focus (EDOF) to provide optimal visual performance from distance to near with minimal ghosting. The EDOF lens provides a series of smooth, non-monotonic, power variations across the optic zone to deliberately manipulate multiple higher-order aberrations. The idea is to achieve an extension in depth of focus that would facilitate a balanced visual performance designed to satisfy presbyopes with low, medium and high-add requirements.

Speaking of the partnership, Prof. Kovin Naidoo, Chief Executive Officer for Brien Holden Vision Institute, said, “We are delighted to be partnering with SynergEyes to bring our novel EDOF designs in myopia and presbyopia management in specialty hybrid contact lenses and make them available to a broader market around the world. This is especially important for myopia, as our mission is to slow the progression of myopia in all children to reduce their risk of permanent vision impairment and address a looming public health crises.”